Found: 42
Select item for more details and to access through your institution.
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97566-z
- By:
- Publication type:
- Article
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Current status of CTCs as liquid biopsy in lung cancer and future directions.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00209
- By:
- Publication type:
- Article
Targeting Angiogenesis in Non-Small Cell Lung Cancer: Agents in Practice and Clinical Development.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 31
- By:
- Publication type:
- Article
Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.
- Published in:
- Nature Medicine, 2008, v. 14, n. 8, p. 822, doi. 10.1038/nm.1790
- By:
- Publication type:
- Article
The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 2, p. 108, doi. 10.1016/j.cllc.2021.11.003
- By:
- Publication type:
- Article
Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Summary of Presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010): Focus on Developmental Therapeutics Related to Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 2, p. 94, doi. 10.1016/j.cllc.2011.03.003
- By:
- Publication type:
- Article
Humanism in Oncology: Patients as Real Time Teachers.
- Published in:
- Journal of Cancer Education, 2007, v. 22, n. 2, p. 131, doi. 10.1007/BF03174363
- By:
- Publication type:
- Article
Investigational agents in the management of non-small cell lung cancer.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 4, p. 275, doi. 10.1007/s11912-009-0039-x
- By:
- Publication type:
- Article
Time to Move Beyond Clinical and Pathologic Classification of BAG.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 10, p. 900
- By:
- Publication type:
- Article
Clonal selection confers distinct evolutionary trajectories in BRAF-driven cancers.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-13161-x
- By:
- Publication type:
- Article
Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 362, doi. 10.1007/s10637-013-0061-6
- By:
- Publication type:
- Article
Impact of EGFR mutation and ALK rearrangement on the outcomes of non–small cell lung cancer patients with brain metastasis.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 2, p. 267, doi. 10.1093/neuonc/noz155
- By:
- Publication type:
- Article
CMET-09. IMPACT OF STEROIDS ON THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi55, doi. 10.1093/neuonc/noy148.222
- By:
- Publication type:
- Article
CMET-03. PHASE 1 TRIAL OF OSIMERTINIB WITH STEREOTACTIC RADIOSURGERY IN EGFR MUTANT LUNG CANCER BRAIN METASTASIS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi54, doi. 10.1093/neuonc/noy148.216
- By:
- Publication type:
- Article
Advanced Non-Small Cell Lung Cancer (NSCLC): Maintenance Therapy for All?
- Published in:
- Current Treatment Options in Oncology, 2012, v. 13, n. 4, p. 478, doi. 10.1007/s11864-012-0209-1
- By:
- Publication type:
- Article
A genetic basis for the variation in the vulnerability of cancer to DNA damage.
- Published in:
- Nature Communications, 2016, v. 7, n. 4, p. 11428, doi. 10.1038/ncomms11428
- By:
- Publication type:
- Article
Tracing of fluoro-gold prelabeled microglia injected into the adult rat brain.
- Published in:
- Glia, 1998, v. 23, n. 1, p. 84, doi. 10.1002/(SICI)1098-1136(199805)23:1<84::AID-GLIA8>3.0.CO;2-4
- By:
- Publication type:
- Article
Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85328-w
- By:
- Publication type:
- Article
Impact of the COVID-19 Pandemic on Healthcare Workers' Risk of Infection and Outcomes in a Large, Integrated Health System.
- Published in:
- JGIM: Journal of General Internal Medicine, 2020, v. 35, n. 11, p. 3293, doi. 10.1007/s11606-020-06171-9
- By:
- Publication type:
- Article
Additional Practice-informing Adverse Event Patterns and Management in the KRYSTAL-1 Phase 2 Study of Adagrasib (MRTX849) in Patients With KRASG12C-mutated Non--Small Cell Lung Cancer.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 350
- By:
- Publication type:
- Article
A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer.
- Published in:
- Thyroid, 2008, v. 18, n. 3, p. 317, doi. 10.1089/thy.2007.0120
- By:
- Publication type:
- Article
Modeling the Cost-Effectiveness of Adjuvant Osimertinib for Patients with Resected EGFR-mutant Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 5, p. 407, doi. 10.1093/oncolo/oyac021
- By:
- Publication type:
- Article
A Review of Immunotherapy for Stage III and Metastatic Non‐Small Cell Lung Cancer and the Rationale for the ECOG‐ACRIN EA5181 Study.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. 523, doi. 10.1002/onco.13725
- By:
- Publication type:
- Article
Cases from the Immune‐Related Adverse Event Tumor Board: Diagnosis and Management of Immune Checkpoint Blockade‐Induced Diabetes.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 921, doi. 10.1634/theoncologist.2019-0806
- By:
- Publication type:
- Article
Phase Ib Study of Crizotinib plus Pembrolizumab in Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer with ALK Translocation.
- Published in:
- Oncologist, 2020, v. 25, n. 7, p. 562, doi. 10.1634/theoncologist.2020-0034
- By:
- Publication type:
- Article
Exploring Ways to Improve Access to and Minimize Risk from Lung Cancer Screening.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 364, doi. 10.1634/theoncologist.2020-0149
- By:
- Publication type:
- Article
An Open‐Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 457, doi. 10.1634/theoncologist.2018-0857
- By:
- Publication type:
- Article
Cases from the irAE Tumor Board: A Multidisciplinary Approach to a Patient Treated with Immune Checkpoint Blockade Who Presented with a New Rash.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 4, doi. 10.1634/theoncologist.2018-0434
- By:
- Publication type:
- Article
Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 11, p. 1298, doi. 10.1634/theoncologist.2015-0136
- By:
- Publication type:
- Article
Combined Inhibition of the VEGFR and EGFR Signaling Pathways in the Treatment of NSCLC.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 399, doi. 10.1634/theoncologist.2008-0276
- By:
- Publication type:
- Article
Correction: Time to initial cancer treatment in the United States and association with survival over time: An observational study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0215108
- By:
- Publication type:
- Article
Time to initial cancer treatment in the United States and association with survival over time: An observational study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0213209
- By:
- Publication type:
- Article
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0197743
- By:
- Publication type:
- Article
Biofeedback Assisted Stress Management in Patients with Lung Cancer: A Feasibility Study.
- Published in:
- Applied Psychophysiology & Biofeedback, 2015, v. 40, n. 3, p. 201, doi. 10.1007/s10484-015-9277-x
- By:
- Publication type:
- Article
Lessons from ADAURA: Can we improve on a positive trial?
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 659, doi. 10.1002/cncr.35112
- By:
- Publication type:
- Article
Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Best Practices in Treatment Selection for Patients With Advanced NSCLC.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prospective Clinical Study of Precision Oncology in Solid Tumors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2016, v. 108, n. 3, p. 1, doi. 10.1093/jnci/djv332
- By:
- Publication type:
- Article